CLEC9A and neoplasm: Likewise, Modak et al. [99] demonstrated that CD11b+CD206+ TAMs are the dominant tumor-infiltrating myeloid cell population with antigen presenting and specific CD8+ T cell activation comparable to cross-presenting CLEC9A + DCs (cDC1) in B16-F10 and CT26 syngeneic tumor models.